WAY-100635 — разлика између измена
Изглед
Садржај обрисан Садржај додат
м normativna kontrola |
|||
(Није приказано 30 међуизмена 4 корисника) | |||
Ред 4: | Ред 4: | ||
| verifiedrevid = 401667456 |
| verifiedrevid = 401667456 |
||
| IUPAC_name = -{''N''}--[2-[4-(2-metoksifenil)-1-piperazinil]etil]- -{''N''}--(2-piridil)cikloheksankarboksamid |
| IUPAC_name = -{''N''}--[2-[4-(2-metoksifenil)-1-piperazinil]etil]- -{''N''}--(2-piridil)cikloheksankarboksamid |
||
| OtherNames = |
|||
| image = WAY-100,635.png |
| image = WAY-100,635.png |
||
| width = 200 |
| width = 200 |
||
| image2 = |
|||
| width2 = |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
Ред 20: | Ред 21: | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 31354 |
| ChEMBL = 31354 |
||
| DrugBank_Ref = |
|||
| DrugBank = |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=25 | H=34 | N=4 | O=2 |
| C=25 | H=34 | N=4 | O=2 |
||
| molecular_weight = 422,56 -{g/mol}- |
| molecular_weight = 422,56 -{g/mol}- |
||
| smiles = |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChI = |
|||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChIKey = |
|||
}} |
}} |
||
-{'''WAY-100,635'''}- je [[piperazin]]ski [[lek]] koji je u širokoj upotrebi u naučnim istraživanjima. Za njega se originalno smatralo da deluje kao selektivni [[5-HT1A|-{5-HT<sub>1A</sub>}-]] [[antagonist (farmakologija)|antagonist]], ali su naknadna istraživanja pokazala da on isto tako deluje kao potentan [[pun agonist]] na [[D4 receptor|D<sub>4</sub>]] receptoru.<ref>{{Cite journal | author = C. A. Fornal, C. W. Metzler, R. A. Gallegos, S. C. Veasey, A. C. McCreary and B. L. Jacobs | title = WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135 | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 278 | issue = 2 | pages = 752–762 | year = 1996 | url = http://jpet.aspetjournals.org/cgi/content/abstract/278/2/752 | pmid = 8768728 }}</ref><ref>{{Cite journal | author = Benjamin R. Chemel, Bryan L. Roth, Blaine Armbruster, Val J. Watts and David E. Nichols | title = WAY-100635 is a potent dopamine D4 receptor agonist | journal = Psychopharmacology |
-{'''WAY-100,635'''}- je [[piperazin]]ski [[lek]] koji je u širokoj upotrebi u naučnim istraživanjima. Za njega se originalno smatralo da deluje kao selektivni [[5-HT1A|-{5-HT<sub>1A</sub>}-]] [[antagonist (farmakologija)|antagonist]], ali su naknadna istraživanja pokazala da on isto tako deluje kao potentan [[agonist (farmakologija)|pun agonist]] na [[D4 receptor|D<sub>4</sub>]] receptoru.<ref>{{Cite journal | author = C. A. Fornal, C. W. Metzler, R. A. Gallegos, S. C. Veasey, A. C. McCreary and B. L. Jacobs | title = WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135 | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 278 | issue = 2 | pages = 752–762 | year = 1996 | url = http://jpet.aspetjournals.org/cgi/content/abstract/278/2/752 | pmid = 8768728 | access-date = 10. 04. 2012 | archive-date = 18. 02. 2009 | archive-url = https://web.archive.org/web/20090218135753/http://jpet.aspetjournals.org/cgi/content/abstract/278/2/752 | url-status = }}</ref><ref>{{Cite journal | author = Benjamin R. Chemel, Bryan L. Roth, Blaine Armbruster, Val J. Watts and David E. Nichols | title = WAY-100635 is a potent dopamine D4 receptor agonist | journal = Psychopharmacology | volume = 188 | issue = 2 | pages = 244–251 | year = 2006 | pmid = 16915381 | url = http://www.springerlink.com/content/vt36125287348028/ | doi = 10.1007/s00213-006-0490-4 }}{{Мртва веза|date=04. 2020 |bot=InternetArchiveBot |fix-attempted=yes }}</ref><ref name="pmid19179855">{{cite journal |vauthors=Marona-Lewicka D, Nichols DE |title=WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation |journal=Behav Pharmacol |volume=20 |issue=1 |pages=114–8 |year=2009 |pmid=19179855 |doi=10.1097/FBP.0b013e3283242f1a |url=}}</ref> On se ponekad naziva nemim antagonistom -{5-HT1A}- receptora.<ref>{{Cite journal | author = A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish | title = Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist | journal = Behavioural Brain Research | volume = 73 | issue = 1-2 | pages = 337–333 | year = 1996 | pmid = 8788530 | doi = 10.1016/0166-4328(96)00118-0 }}</ref> -{WAY-100,635}- i -{[[WAY-100,135]]}- su hemijski slični. |
||
== Reference == |
== Reference == |
||
Ред 32: | Ред 40: | ||
== Spoljašnje veze == |
== Spoljašnje veze == |
||
{{Portal-lat|Medicina|Hemija}} |
|||
* {{Cite web |
* {{Cite web |
||
| url = http://www.turkupetcentre.net/analysis/doc/tracer/way100635.html |
| url = http://www.turkupetcentre.net/analysis/doc/tracer/way100635.html |
||
Ред 42: | Ред 51: | ||
{{Serotonergici-lat}} |
{{Serotonergici-lat}} |
||
{{Dopaminergici-lat}} |
{{Dopaminergici-lat}} |
||
{{normativna kontrola}} |
|||
[[Категорија:Серотонински антагонисти]] |
|||
[[Категорија:Допамински агонисти]] |
|||
[[Категорија:Пиперазини]] |
|||
[[Категорија:Фенолни етри]] |
|||
[[Категорија:Амиди]] |
|||
[[Категорија:Пиридини]] |
Тренутна верзија на датум 13. јануар 2024. у 22:25
IUPAC ime | |
---|---|
N-[2-[4-(2-metoksifenil)-1-piperazinil]etil]- N-(2-piridil)cikloheksankarboksamid | |
Identifikatori | |
CAS broj | 146714-97-8 |
ATC kod | none |
PubChem | CID 5684 |
IUPHAR/BPS | 80 |
ChEMBL | CHEMBL31354 |
Hemijski podaci | |
Formula | C25H34N4O2 |
Molarna masa | 422,56 g/mol |
WAY-100,635 je piperazinski lek koji je u širokoj upotrebi u naučnim istraživanjima. Za njega se originalno smatralo da deluje kao selektivni 5-HT1A antagonist, ali su naknadna istraživanja pokazala da on isto tako deluje kao potentan pun agonist na D4 receptoru.[1][2][3] On se ponekad naziva nemim antagonistom 5-HT1A receptora.[4] WAY-100,635 i WAY-100,135 su hemijski slični.
Reference
[уреди | уреди извор]- ^ C. A. Fornal, C. W. Metzler, R. A. Gallegos, S. C. Veasey, A. C. McCreary and B. L. Jacobs (1996). „WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135”. The Journal of Pharmacology and Experimental Therapeutics. 278 (2): 752–762. PMID 8768728. Архивирано из оригинала 18. 02. 2009. г. Приступљено 10. 04. 2012.
- ^ Benjamin R. Chemel, Bryan L. Roth, Blaine Armbruster, Val J. Watts and David E. Nichols (2006). „WAY-100635 is a potent dopamine D4 receptor agonist”. Psychopharmacology. 188 (2): 244—251. PMID 16915381. doi:10.1007/s00213-006-0490-4.[мртва веза]
- ^ Marona-Lewicka D, Nichols DE (2009). „WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation”. Behav Pharmacol. 20 (1): 114—8. PMID 19179855. doi:10.1097/FBP.0b013e3283242f1a.
- ^ A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish (1996). „Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist”. Behavioural Brain Research. 73 (1-2): 337—333. PMID 8788530. doi:10.1016/0166-4328(96)00118-0.
Spoljašnje veze
[уреди | уреди извор]- Vesa Oikonen (2007). „Quantification of (carbonyl-11C)WAY-100635 PET studies”. Turku PET center.